Proliferation Dynamics of Acute Myeloid Leukaemia and Haematopoietic Progenitors Competing for Bone Marrow Space

Overview

Journal Nat Commun

Specialty Biology

Date 2018 Feb 8

PMID 29410432

Citations 46

Authors

O Akinduro

T S Weber

H Ang

M L R Haltalli

N Ruivo

D Duarte

N M Rashidi

E D Hawkins

K R Duffy

C Lo Celso

Affiliations

Soon will be listed here.

Abstract

Leukaemia progressively invades bone marrow (BM), outcompeting healthy haematopoiesis by mechanisms that are not fully understood. Combining cell number measurements with a short-timescale dual pulse labelling method, we simultaneously determine the proliferation dynamics of primitive haematopoietic compartments and acute myeloid leukaemia (AML). We observe an unchanging proportion of AML cells entering S phase per hour throughout disease progression, with substantial BM egress at high levels of infiltration. For healthy haematopoiesis, we find haematopoietic stem cells (HSCs) make a significant contribution to cell production, but we phenotypically identify a quiescent subpopulation with enhanced engraftment ability. During AML progression, we observe that multipotent progenitors maintain a constant proportion entering S phase per hour, despite a dramatic decrease in the overall population size. Primitive populations are lost from BM with kinetics that are consistent with ousting irrespective of cell cycle state, with the exception of the quiescent HSC subpopulation, which is more resistant to elimination.

Citing Articles

Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic system.

Jang G, Park R, Esteva E, Hsu P, Feng J, Upadhaya S J Exp Med. 2025; 222(6).

PMID: 40072317 PMC: 11899982. DOI: 10.1084/jem.20240587.

Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete Remission.

Xing T, Hu L, Zhao H, Li C, Wang Z, Shen M Nat Commun. 2024; 15(1):10832.

PMID: 39737962 PMC: 11686104. DOI: 10.1038/s41467-024-55051-x.

Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia.

Mesaros O, Onciul M, Matei E, Joldes C, Jimbu L, Neaga A Biomedicines. 2024; 12(10).

PMID: 39457618 PMC: 11505058. DOI: 10.3390/biomedicines12102306.

In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions.

Atkin-Smith G, Santavanond J, Light A, Rimes J, Samson A, Er J Nat Commun. 2024; 15(1):8802.

PMID: 39438460 PMC: 11496675. DOI: 10.1038/s41467-024-52867-5.

Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia.

Zhang Z, Huang J, Zhang Z, Shen H, Tang X, Wu D Biomark Res. 2024; 12(1):60.

PMID: 38858750 PMC: 11165883. DOI: 10.1186/s40364-024-00600-1.

References

Pietras E, Reynaud D, Kang Y, Carlin D, Calero-Nieto F, Leavitt A . Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 2015; 17(1):35-46. PMC: 4542150. DOI: 10.1016/j.stem.2015.05.003. View

Cheng H, Hao S, Liu Y, Pang Y, Ma S, Dong F . Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation. Blood. 2015; 126(11):1302-13. PMC: 4574014. DOI: 10.1182/blood-2015-01-623645. View

Qiu J, Papatsenko D, Niu X, Schaniel C, Moore K . Divisional history and hematopoietic stem cell function during homeostasis. Stem Cell Reports. 2014; 2(4):473-90. PMC: 3986626. DOI: 10.1016/j.stemcr.2014.01.016. View

Bryder D, Rossi D, Weissman I . Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol. 2006; 169(2):338-46. PMC: 1698791. DOI: 10.2353/ajpath.2006.060312. View

Krivtsov A, Twomey D, Feng Z, Stubbs M, Wang Y, Faber J . Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature. 2006; 442(7104):818-22. DOI: 10.1038/nature04980. View

Uy G, Rettig M, Motabi I, McFarland K, Trinkaus K, Hladnik L . A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood. 2012; 119(17):3917-24. PMC: 3350358. DOI: 10.1182/blood-2011-10-383406. View

Duan C, Shi J, Chen J, Wang B, Yu Y, Qin X . Leukemia propagating cells rebuild an evolving niche in response to therapy. Cancer Cell. 2014; 25(6):778-93. DOI: 10.1016/j.ccr.2014.04.015. View

Wilson A, Laurenti E, Oser G, van der Wath R, Blanco-Bose W, Jaworski M . Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135(6):1118-29. DOI: 10.1016/j.cell.2008.10.048. View

Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y . Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell. 2014; 15(3):365-375. PMC: 4156919. DOI: 10.1016/j.stem.2014.06.020. View

10.

Gothot A, Pyatt R, McMahel J, Rice S, Srour E . Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood. 1997; 90(11):4384-93. View

11.

Hawkins E, Hommel M, Turner M, Battye F, Markham J, Hodgkin P . Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat Protoc. 2007; 2(9):2057-67. DOI: 10.1038/nprot.2007.297. View

12.

Baldridge M, King K, Boles N, Weksberg D, Goodell M . Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 2010; 465(7299):793-7. PMC: 2935898. DOI: 10.1038/nature09135. View

13.

Essers M, Offner S, Blanco-Bose W, Waibler Z, Kalinke U, Duchosal M . IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 2009; 458(7240):904-8. DOI: 10.1038/nature07815. View

14.

Pei W, Feyerabend T, Rossler J, Wang X, Postrach D, Busch K . Polylox barcoding reveals haematopoietic stem cell fates realized in vivo. Nature. 2017; 548(7668):456-460. PMC: 5905670. DOI: 10.1038/nature23653. View

15.

Busch K, Klapproth K, Barile M, Flossdorf M, Holland-Letz T, Schlenner S . Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature. 2015; 518(7540):542-6. DOI: 10.1038/nature14242. View

16.

Sawai C, Babovic S, Upadhaya S, Knapp D, Lavin Y, Lau C . Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals. Immunity. 2016; 45(3):597-609. PMC: 5054720. DOI: 10.1016/j.immuni.2016.08.007. View

17.

Kondo M, Wagers A, Manz M, Prohaska S, Scherer D, Beilhack G . Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003; 21:759-806. DOI: 10.1146/annurev.immunol.21.120601.141007. View

18.

Cappella P, Gasparri F, Pulici M, Moll J . A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A. 2008; 73(7):626-36. DOI: 10.1002/cyto.a.20582. View

19.

Boles N, Lin K, Lukov G, Bowman T, Baldridge M, Goodell M . CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation. Blood. 2011; 118(1):80-7. PMC: 3139389. DOI: 10.1182/blood-2010-12-322339. View

20.

Ritter M, Fowler J, Kim Y, Gilchrist K, Morrissey L, Kinsella T . Tumor cell kinetics using two labels and flow cytometry. Cytometry. 1994; 16(1):49-58. DOI: 10.1002/cyto.990160108. View